NFGH
JBIO

Nan Fung Group Holdings’s Jade Biosciences JBIO Stock Holding History

Nan Fung Group Holdings’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,370
Closed -$100K – 36
2024
Q3 		$100K Hold
1,370
– – 0.09% 37
2024
Q2 		$79.6K Hold
1,370
– – 0.08% 42
2024
Q1 		$1.42M Hold
1,370
– – 1.31% 23
2023
Q4 		$1.08M Hold
1,370
– – 0.68% 21
2023
Q3 		$650K Hold
1,370
– – 0.53% 24
2023
Q2 		$822K Hold
1,370
– – 0.53% 23
2023
Q1 		$967K Sell
1,370
-76
-5% -$63K 0.66% 24
2022
Q4 		$1.48M Buy
+1,446
New +$1.05M 1.02% 16

Other funds holding JBIO

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
AI
Allostery Investments Stamford, Connecticut $7.85M AUM

Nan Fung Group Holdings's JBIO Position: Q4 2024 in Review

Nan Fung Group Holdings sold out of Jade Biosciences (JBIO) in Q4 2024, closing a stake of 1,370 shares — an estimated $100K sold.

Nan Fung Group Holdings first reported a position in JBIO in Q4 2022 and held it in 8 quarters. The position peaked at $1.48M in Q4 2022. 78 funds tracked by Wall St. Rank hold JBIO as of Q4 2024.

  • Nan Fung Group Holdings reported no remaining Jade Biosciences position as of Q4 2024 after selling out during the quarter.
  • Nan Fung Group Holdings sold 1,370 Jade Biosciences shares in Q4 2024, an estimated $100K.
  • Nan Fung Group Holdings first reported a position in Jade Biosciences in Q4 2022 and held it in 8 quarters.
  • Nan Fung Group Holdings's Jade Biosciences position peaked at $1.48M in Q4 2022.
  • 78 funds tracked by Wall St. Rank held Jade Biosciences as of Q4 2024.

Based on Nan Fung Group Holdings's 13F filing for Q4 2024, filed 13 Feb 2025.